Copyright Reports & Markets. All rights reserved.

Global Cyanocobalamin Injection Market Insights, Forecast to 2025

Request for Sample of this report
Buy now

1 Study Coverage

  • 1.1 Cyanocobalamin Injection Product Introduction
  • 1.2 Market Segments
  • 1.3 Key Cyanocobalamin Injection Manufacturers Covered: Ranking by Revenue
  • 1.4 Market by Type
    • 1.4.1 Global Cyanocobalamin Injection Market Size Growth Rate by Type
    • 1.4.2 Vitamins
    • 1.4.3 Supplements
  • 1.5 Market by Application
    • 1.5.1 Global Cyanocobalamin Injection Market Size Growth Rate by Application
    • 1.5.2 Hospitals
    • 1.5.3 Clinics
    • 1.5.4 Others
  • 1.6 Study Objectives
  • 1.7 Years Considered

2 Executive Summary

  • 2.1 Global Cyanocobalamin Injection Market Size, Estimates and Forecasts
    • 2.1.1 Global Cyanocobalamin Injection Revenue 2015-2026
    • 2.1.2 Global Cyanocobalamin Injection Sales 2015-2026
  • 2.2 Global Cyanocobalamin Injection, Market Size by Producing Regions: 2015 VS 2020 VS 2026
    • 2.2.1 Global Cyanocobalamin Injection Retrospective Market Scenario in Sales by Region: 2015-2020
    • 2.2.2 Global Cyanocobalamin Injection Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global Cyanocobalamin Injection Competitor Landscape by Players

  • 3.1 Cyanocobalamin Injection Sales by Manufacturers
    • 3.1.1 Cyanocobalamin Injection Sales by Manufacturers (2015-2020)
    • 3.1.2 Cyanocobalamin Injection Sales Market Share by Manufacturers (2015-2020)
  • 3.2 Cyanocobalamin Injection Revenue by Manufacturers
    • 3.2.1 Cyanocobalamin Injection Revenue by Manufacturers (2015-2020)
    • 3.2.2 Cyanocobalamin Injection Revenue Share by Manufacturers (2015-2020)
    • 3.2.3 Global Cyanocobalamin Injection Market Concentration Ratio (CR5 and HHI) (2015-2020)
    • 3.2.4 Global Top 10 and Top 5 Companies by Cyanocobalamin Injection Revenue in 2019
    • 3.2.5 Global Cyanocobalamin Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Cyanocobalamin Injection Price by Manufacturers
  • 3.4 Cyanocobalamin Injection Manufacturing Base Distribution, Product Types
    • 3.4.1 Cyanocobalamin Injection Manufacturers Manufacturing Base Distribution, Headquarters
    • 3.4.2 Manufacturers Cyanocobalamin Injection Product Type
    • 3.4.3 Date of International Manufacturers Enter into Cyanocobalamin Injection Market
  • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

  • 4.1 Global Cyanocobalamin Injection Market Size by Type (2015-2020)
    • 4.1.1 Global Cyanocobalamin Injection Sales by Type (2015-2020)
    • 4.1.2 Global Cyanocobalamin Injection Revenue by Type (2015-2020)
    • 4.1.3 Cyanocobalamin Injection Average Selling Price (ASP) by Type (2015-2026)
  • 4.2 Global Cyanocobalamin Injection Market Size Forecast by Type (2021-2026)
    • 4.2.1 Global Cyanocobalamin Injection Sales Forecast by Type (2021-2026)
    • 4.2.2 Global Cyanocobalamin Injection Revenue Forecast by Type (2021-2026)
    • 4.2.3 Cyanocobalamin Injection Average Selling Price (ASP) Forecast by Type (2021-2026)
  • 4.3 Global Cyanocobalamin Injection Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)

  • 5.1 Global Cyanocobalamin Injection Market Size by Application (2015-2020)
    • 5.1.1 Global Cyanocobalamin Injection Sales by Application (2015-2020)
    • 5.1.2 Global Cyanocobalamin Injection Revenue by Application (2015-2020)
    • 5.1.3 Cyanocobalamin Injection Price by Application (2015-2020)
  • 5.2 Cyanocobalamin Injection Market Size Forecast by Application (2021-2026)
    • 5.2.1 Global Cyanocobalamin Injection Sales Forecast by Application (2021-2026)
    • 5.2.2 Global Cyanocobalamin Injection Revenue Forecast by Application (2021-2026)
    • 5.2.3 Global Cyanocobalamin Injection Price Forecast by Application (2021-2026)

6 North America

  • 6.1 North America Cyanocobalamin Injection by Country
    • 6.1.1 North America Cyanocobalamin Injection Sales by Country
    • 6.1.2 North America Cyanocobalamin Injection Revenue by Country
    • 6.1.3 U.S.
    • 6.1.4 Canada
  • 6.2 North America Cyanocobalamin Injection Market Facts & Figures by Type
  • 6.3 North America Cyanocobalamin Injection Market Facts & Figures by Application

7 Europe

  • 7.1 Europe Cyanocobalamin Injection by Country
    • 7.1.1 Europe Cyanocobalamin Injection Sales by Country
    • 7.1.2 Europe Cyanocobalamin Injection Revenue by Country
    • 7.1.3 Germany
    • 7.1.4 France
    • 7.1.5 U.K.
    • 7.1.6 Italy
    • 7.1.7 Russia
  • 7.2 Europe Cyanocobalamin Injection Market Facts & Figures by Type
  • 7.3 Europe Cyanocobalamin Injection Market Facts & Figures by Application

8 Asia Pacific

  • 8.1 Asia Pacific Cyanocobalamin Injection by Region
    • 8.1.1 Asia Pacific Cyanocobalamin Injection Sales by Region
    • 8.1.2 Asia Pacific Cyanocobalamin Injection Revenue by Region
    • 8.1.3 China
    • 8.1.4 Japan
    • 8.1.5 South Korea
    • 8.1.6 India
    • 8.1.7 Australia
    • 8.1.8 Taiwan
    • 8.1.9 Indonesia
    • 8.1.10 Thailand
    • 8.1.11 Malaysia
    • 8.1.12 Philippines
    • 8.1.13 Vietnam
  • 8.2 Asia Pacific Cyanocobalamin Injection Market Facts & Figures by Type
  • 8.3 Asia Pacific Cyanocobalamin Injection Market Facts & Figures by Application

9 Latin America

  • 9.1 Latin America Cyanocobalamin Injection by Country
    • 9.1.1 Latin America Cyanocobalamin Injection Sales by Country
    • 9.1.2 Latin America Cyanocobalamin Injection Revenue by Country
    • 9.1.3 Mexico
    • 9.1.4 Brazil
    • 9.1.5 Argentina
  • 9.2 Central & South America Cyanocobalamin Injection Market Facts & Figures by Type
  • 9.3 Central & South America Cyanocobalamin Injection Market Facts & Figures by Application

10 Middle East and Africa

  • 10.1 Middle East and Africa Cyanocobalamin Injection by Country
    • 10.1.1 Middle East and Africa Cyanocobalamin Injection Sales by Country
    • 10.1.2 Middle East and Africa Cyanocobalamin Injection Revenue by Country
    • 10.1.3 Turkey
    • 10.1.4 Saudi Arabia
    • 10.1.5 U.A.E
  • 10.2 Middle East and Africa Cyanocobalamin Injection Market Facts & Figures by Type
  • 10.3 Middle East and Africa Cyanocobalamin Injection Market Facts & Figures by Application

11 Company Profiles

  • 11.1 Luitpold Pharmaceuticals
    • 11.1.1 Luitpold Pharmaceuticals Corporation Information
    • 11.1.2 Luitpold Pharmaceuticals Description and Business Overview
    • 11.1.3 Luitpold Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
    • 11.1.4 Luitpold Pharmaceuticals Cyanocobalamin Injection Products Offered
    • 11.1.5 Luitpold Pharmaceuticals Related Developments
  • 11.2 Luitpold Pharmaceuticals (Daiichi Sankyo)
    • 11.2.1 Luitpold Pharmaceuticals (Daiichi Sankyo) Corporation Information
    • 11.2.2 Luitpold Pharmaceuticals (Daiichi Sankyo) Description and Business Overview
    • 11.2.3 Luitpold Pharmaceuticals (Daiichi Sankyo) Sales, Revenue and Gross Margin (2015-2020)
    • 11.2.4 Luitpold Pharmaceuticals (Daiichi Sankyo) Cyanocobalamin Injection Products Offered
    • 11.2.5 Luitpold Pharmaceuticals (Daiichi Sankyo) Related Developments
  • 11.3 Endo International
    • 11.3.1 Endo International Corporation Information
    • 11.3.2 Endo International Description and Business Overview
    • 11.3.3 Endo International Sales, Revenue and Gross Margin (2015-2020)
    • 11.3.4 Endo International Cyanocobalamin Injection Products Offered
    • 11.3.5 Endo International Related Developments
  • 11.4 Bristol-Myers Squibb
    • 11.4.1 Bristol-Myers Squibb Corporation Information
    • 11.4.2 Bristol-Myers Squibb Description and Business Overview
    • 11.4.3 Bristol-Myers Squibb Sales, Revenue and Gross Margin (2015-2020)
    • 11.4.4 Bristol-Myers Squibb Cyanocobalamin Injection Products Offered
    • 11.4.5 Bristol-Myers Squibb Related Developments
  • 11.5 Sanofi-Aventis
    • 11.5.1 Sanofi-Aventis Corporation Information
    • 11.5.2 Sanofi-Aventis Description and Business Overview
    • 11.5.3 Sanofi-Aventis Sales, Revenue and Gross Margin (2015-2020)
    • 11.5.4 Sanofi-Aventis Cyanocobalamin Injection Products Offered
    • 11.5.5 Sanofi-Aventis Related Developments
  • 11.6 Jamieson
    • 11.6.1 Jamieson Corporation Information
    • 11.6.2 Jamieson Description and Business Overview
    • 11.6.3 Jamieson Sales, Revenue and Gross Margin (2015-2020)
    • 11.6.4 Jamieson Cyanocobalamin Injection Products Offered
    • 11.6.5 Jamieson Related Developments
  • 11.7 Teva (Actavis)
    • 11.7.1 Teva (Actavis) Corporation Information
    • 11.7.2 Teva (Actavis) Description and Business Overview
    • 11.7.3 Teva (Actavis) Sales, Revenue and Gross Margin (2015-2020)
    • 11.7.4 Teva (Actavis) Cyanocobalamin Injection Products Offered
    • 11.7.5 Teva (Actavis) Related Developments
  • 11.8 Merck
    • 11.8.1 Merck Corporation Information
    • 11.8.2 Merck Description and Business Overview
    • 11.8.3 Merck Sales, Revenue and Gross Margin (2015-2020)
    • 11.8.4 Merck Cyanocobalamin Injection Products Offered
    • 11.8.5 Merck Related Developments
  • 11.9 Mylan
    • 11.9.1 Mylan Corporation Information
    • 11.9.2 Mylan Description and Business Overview
    • 11.9.3 Mylan Sales, Revenue and Gross Margin (2015-2020)
    • 11.9.4 Mylan Cyanocobalamin Injection Products Offered
    • 11.9.5 Mylan Related Developments
  • 11.10 Bayer HealthCare
    • 11.10.1 Bayer HealthCare Corporation Information
    • 11.10.2 Bayer HealthCare Description and Business Overview
    • 11.10.3 Bayer HealthCare Sales, Revenue and Gross Margin (2015-2020)
    • 11.10.4 Bayer HealthCare Cyanocobalamin Injection Products Offered
    • 11.10.5 Bayer HealthCare Related Developments
  • 11.1 Luitpold Pharmaceuticals
    • 11.1.1 Luitpold Pharmaceuticals Corporation Information
    • 11.1.2 Luitpold Pharmaceuticals Description and Business Overview
    • 11.1.3 Luitpold Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
    • 11.1.4 Luitpold Pharmaceuticals Cyanocobalamin Injection Products Offered
    • 11.1.5 Luitpold Pharmaceuticals Related Developments
  • 11.12 ANGELINI
    • 11.12.1 ANGELINI Corporation Information
    • 11.12.2 ANGELINI Description and Business Overview
    • 11.12.3 ANGELINI Sales, Revenue and Gross Margin (2015-2020)
    • 11.12.4 ANGELINI Products Offered
    • 11.12.5 ANGELINI Related Developments
  • 11.13 Biological E
    • 11.13.1 Biological E Corporation Information
    • 11.13.2 Biological E Description and Business Overview
    • 11.13.3 Biological E Sales, Revenue and Gross Margin (2015-2020)
    • 11.13.4 Biological E Products Offered
    • 11.13.5 Biological E Related Developments
  • 11.14 CCEPCD
    • 11.14.1 CCEPCD Corporation Information
    • 11.14.2 CCEPCD Description and Business Overview
    • 11.14.3 CCEPCD Sales, Revenue and Gross Margin (2015-2020)
    • 11.14.4 CCEPCD Products Offered
    • 11.14.5 CCEPCD Related Developments
  • 11.15 Huaxin Pharmaceutical
    • 11.15.1 Huaxin Pharmaceutical Corporation Information
    • 11.15.2 Huaxin Pharmaceutical Description and Business Overview
    • 11.15.3 Huaxin Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
    • 11.15.4 Huaxin Pharmaceutical Products Offered
    • 11.15.5 Huaxin Pharmaceutical Related Developments

12 Future Forecast by Regions (Countries) (2021-2026)

  • 12.1 Cyanocobalamin Injection Market Estimates and Projections by Region
    • 12.1.1 Global Cyanocobalamin Injection Sales Forecast by Regions 2021-2026
    • 12.1.2 Global Cyanocobalamin Injection Revenue Forecast by Regions 2021-2026
  • 12.2 North America Cyanocobalamin Injection Market Size Forecast (2021-2026)
    • 12.2.1 North America: Cyanocobalamin Injection Sales Forecast (2021-2026)
    • 12.2.2 North America: Cyanocobalamin Injection Revenue Forecast (2021-2026)
    • 12.2.3 North America: Cyanocobalamin Injection Market Size Forecast by Country (2021-2026)
  • 12.3 Europe Cyanocobalamin Injection Market Size Forecast (2021-2026)
    • 12.3.1 Europe: Cyanocobalamin Injection Sales Forecast (2021-2026)
    • 12.3.2 Europe: Cyanocobalamin Injection Revenue Forecast (2021-2026)
    • 12.3.3 Europe: Cyanocobalamin Injection Market Size Forecast by Country (2021-2026)
  • 12.4 Asia Pacific Cyanocobalamin Injection Market Size Forecast (2021-2026)
    • 12.4.1 Asia Pacific: Cyanocobalamin Injection Sales Forecast (2021-2026)
    • 12.4.2 Asia Pacific: Cyanocobalamin Injection Revenue Forecast (2021-2026)
    • 12.4.3 Asia Pacific: Cyanocobalamin Injection Market Size Forecast by Region (2021-2026)
  • 12.5 Latin America Cyanocobalamin Injection Market Size Forecast (2021-2026)
    • 12.5.1 Latin America: Cyanocobalamin Injection Sales Forecast (2021-2026)
    • 12.5.2 Latin America: Cyanocobalamin Injection Revenue Forecast (2021-2026)
    • 12.5.3 Latin America: Cyanocobalamin Injection Market Size Forecast by Country (2021-2026)
  • 12.6 Middle East and Africa Cyanocobalamin Injection Market Size Forecast (2021-2026)
    • 12.6.1 Middle East and Africa: Cyanocobalamin Injection Sales Forecast (2021-2026)
    • 12.6.2 Middle East and Africa: Cyanocobalamin Injection Revenue Forecast (2021-2026)
    • 12.6.3 Middle East and Africa: Cyanocobalamin Injection Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

  • 13.1 Market Opportunities and Drivers
  • 13.2 Market Challenges
  • 13.3 Market Risks/Restraints
  • 13.4 Porter's Five Forces Analysis
  • 13.5 Primary Interviews with Key Cyanocobalamin Injection Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis

  • 14.1 Value Chain Analysis
  • 14.2 Cyanocobalamin Injection Customers
  • 14.3 Sales Channels Analysis
    • 14.3.1 Sales Channels
    • 14.3.2 Distributors

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Research Methodology
      • 16.1.1 Methodology/Research Approach
      • 16.1.2 Data Source
    • 16.2 Author Details

    Cyanocobalamin Injection market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Cyanocobalamin Injection market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

    Segment by Type, the Cyanocobalamin Injection market is segmented into
    Vitamins
    Supplements

    Segment by Application, the Cyanocobalamin Injection market is segmented into
    Hospitals
    Clinics
    Others

    Regional and Country-level Analysis
    The Cyanocobalamin Injection market is analysed and market size information is provided by regions (countries).
    The key regions covered in the Cyanocobalamin Injection market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
    The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
    Competitive Landscape and Cyanocobalamin Injection Market Share Analysis
    Cyanocobalamin Injection market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Cyanocobalamin Injection business, the date to enter into the Cyanocobalamin Injection market, Cyanocobalamin Injection product introduction, recent developments, etc.

    The major vendors covered:
    Luitpold Pharmaceuticals
    Luitpold Pharmaceuticals (Daiichi Sankyo)
    Endo International
    Bristol-Myers Squibb
    Sanofi-Aventis
    Jamieson
    Teva (Actavis)
    Merck
    Mylan
    Bayer HealthCare
    Pfizer
    ANGELINI
    Biological E
    CCEPCD
    Huaxin Pharmaceutical

    Buy now